Northland Securities Downgrades Cardlytics(CDLX.US) to Hold Rating, Cuts Target Price to $5
Northland Securities Downgrades Cardlytics (CDLX) to a Hold
BofA Securities Downgrades Cardlytics(CDLX.US) to Sell Rating
Bank of America Securities Remains a Sell on Cardlytics (CDLX)
Cardlytics Analyst Ratings
B of A Securities Downgrades Cardlytics to Underperform, Lowers Price Target to $3.5
Craig-Hallum Downgrades Cardlytics(CDLX.US) to Hold Rating
Northland Capital Markets Maintains Outperform on Cardlytics, Lowers Price Target to $7
Cardlytics (CDLX) Was Downgraded to a Hold Rating at Needham
Hold Rating on Cardlytics Amid Operational Changes and CEO Transition
Cardlytics Price Target Cut to $5.00/Share From $18.00 by Lake Street
Cardlytics Analyst Ratings
Lake Street Downgrades Cardlytics to Hold, Lowers Price Target to $5
Craig-Hallum Maintains Cardlytics(CDLX.US) With Buy Rating
Cardlytics (CDLX) Receives a Buy From Craig-Hallum
B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
Cardlytics Analyst Ratings
Northland Capital Markets Initiates Coverage On Cardlytics With Outperform Rating, Announces Price Target of $14
Cardlytics Analyst Ratings
Needham Reiterates Buy on Cardlytics, Maintains $12 Price Target